B. Riley raised the firm’s price target on Diversified Healthcare Trust to $6 from $5 and keeps a Buy rating on the shares. The company’s Q2 results were in-line, driven by expected senior housing improvement, but there was also “material compelling news that should help drive the shares higher,” the analyst tells investors in a research note. The firm says the senior housing recovery is unfolding as expected.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DHC: